The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer
On April 18, 2024, the Food and Drug Administration approved alectinib for adjuvant treatment following…
